Venlafaxine XR Recall
Summary
Health Canada has issued a Type II recall for VENLAFAXINE XR 75mg capsules due to dissolution testing being out of specification. Retailers are instructed to remove the affected product from shelves. Consumers should consult a healthcare provider before discontinuing use.
What changed
Health Canada has initiated a Type II recall for VENLAFAXINE XR 75mg extended-release capsules, Lot 2505003230, manufactured by Pro-Doc Ltée. The recall is due to the drug's dissolution testing results being out of specification, indicating a potential quality issue. The depth of the recall is at the retail level.
Retailers must remove the affected product from their inventory. Consumers are advised to consult their healthcare provider before stopping the use of this medication or if they have any health concerns related to it. The company should be contacted for questions regarding the recall. Consumers are also reminded to report any adverse reactions or safety complaints to Health Canada.
What to do next
- Remove affected VENLAFAXINE XR 75mg capsules (Lot 2505003230) from retail inventory.
- Advise consumers to consult healthcare providers before discontinuing use.
- Report any health product-related side effects or safety complaints to Health Canada.
Source document (simplified)
Health product recall
VENLAFAXINE XR: out of specification
Brand(s)
Last updated
2026-03-10
Summary
Product VENLAFAXINE XR 75mg Issue Health products - Product quality What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
| --- | --- | --- | --- | --- | --- |
| VENLAFAXINE XR | VENLAFAXINE XR | DIN 02339250 | Capsule (extended release) | Venlafaxine (Venlafaxine Hydrochloride) 75mg | 2505003230 |
Issue
Dissolution is out of specification in the affected batch.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
2026-03-10
Alert / recall type Health product recall Category Health products - Drugs Companies
Pro-Doc Lté.
2925 boul. Industriel,
Laval, Qc,
H7L 3W9
Published by Health Canada Audience General public Healthcare Industry Recall class Type II Recall date
2026-03-10
Identification number RA-81722
Get notified
Receive emails about new and updated recall and safety alerts.
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Health Canada Recalls & Safety Alerts publishes new changes.